Xiuling Lv
Key Laboratory Of Imaging Diagnosis And Minimally Invasive Intervention Research
Lishui, 323000, China
Lishui, 323000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Multifunctional Microspheres Dual-Loaded with Doxorubicin and Sodium Bicarbonate Nanoparticles to Introduce Synergistic Trimodal Interventional Therapy.
Journal: ACS applied bio materials
Published: January 11, 2022
Corrigendum: Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress.
Journal: Frontiers in pharmacology
Published: December 20, 2021
HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma.
Journal: Biomaterials
Published: March 16, 2021
Construction of a novel radiomics nomogram for the prediction of aggressive intrasegmental recurrence of HCC after radiofrequency ablation.
Journal: European journal of radiology
Published: February 23, 2021
Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma.
Journal: Cell communication and signaling : CCS
Published: October 23, 2020
Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
Journal: European radiology
Published: September 04, 2020
Non-invasive evaluation for benign and malignant subcentimeter pulmonary ground-glass nodules (≤1 cm) based on CT texture analysis.
Journal: The British journal of radiology
Published: July 21, 2020
Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma.
Journal: Cell communication and signaling : CCS
Published: January 18, 2020
Identification and validation of the angiogenic genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma.
Journal: Aging
Published: December 25, 2019
Identifying Apoptosis-Related Transcriptomic Aberrations and Revealing Clinical Relevance as Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma.
Journal: Frontiers in oncology
Published: December 11, 2019
Last Updated: 09/26/2026